CHEBI:140272 - 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
ChEBI ID CHEBI:140272
ChEBI ASCII Name 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid
Definition A docosanoid that is (14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid carrying three hydroxy substituents at positions 7, 16 and 17. An intermediate of specialised proresolving mediators
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Bijay
Supplier Information
Download Molfile XML SDF
Formula C22H34O5
Net Charge 0
Average Mass 378.503
Monoisotopic Mass 378.24062
InChI InChI=1S/C22H34O5/c1-2-3-9-16-20(24)21(25)17-12-7-5-4-6-10-14-19(23)15-11-8-13-18-22(26)27/h3-7,9-10,12,14,17,19-21,23-25H,2,8,11,13,15-16,18H2,1H3,(H,26,27)/b6-4?,7-5?,9-3-,14-10?,17-12+
InChIKey LDVCZYSUILUYKN-OSLFFFSGSA-N
SMILES C(=CC=C/C=C/C(C(C/C=C\CC)O)O)C=CC(CCCCCC(O)=O)O
Metabolite of Species Details
Homo sapiens (NCBI:txid9606) See: PubMed
Roles Classification
Chemical Role(s): Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
Application(s): specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272) has role human xenobiotic metabolite (CHEBI:76967)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272) has role specialised pro-resolving mediator (CHEBI:140399)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272) is a docosanoid (CHEBI:131863)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272) is a hydroxy polyunsaturated fatty acid (CHEBI:140345)
7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272) is conjugate acid of 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate (CHEBI:140416)
Incoming 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoate (CHEBI:140416) is conjugate base of 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272)
IUPAC Name
(14E,19Z)-7,16,17-trihydroxydocosa-8,10,12,14,19-pentaenoic acid
Synonyms Sources
7,16,17-trihydroxy-(8,10,12,14E,19Z)-docosapentaenoic acid ChEBI
7,16,17-trihydroxy-omega3-docosapentaenoic acid ChEBI
resolvin D2n-3 DPA ChEBI
RvD2n-3 DPA SUBMITTER
Citations Waiting for Citations Types Sources
23736886 PubMed citation Europe PMC
28356517 PubMed citation Europe PMC
28408222 PubMed citation Europe PMC
Last Modified
13 March 2018